Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Hive Health
AddedMar 17, 2024
UpdatedJul 3, 2026
Hive Health

Hive Health

Seed

Hive Health is a Philippine HMO administrator that offers digital health benefit plans for small and growing employers.

Founded
2021
Accelerator
Y Combinator logoY CombinatorS21
Overview
Compare
Fundraising
Employees
Website

Hive Health operates a digital health benefits platform that sells HMO-administered plans to small and growing Philippine employers. Its plans bundle inpatient, outpatient, emergency, and dental coverage with add-ons such as teleconsultations, mental health consults, medicine reimbursement, maternity cash assistance, and annual physical exams. Members use an online portal to find providers, request Letters of Authorization, file claims, and view records, while HR teams manage enrollment, invoices, and pre-employment exams through a dashboard.

The company primarily serves small and medium enterprises and growing companies in the Philippines, covering employees and their dependents. It competes in the employer-sponsored health insurance and healthtech sector as a licensed HMO-backed administrator, generating recurring revenue through employer-paid premiums.

Hive Health - Quick Facts

When was Hive Health founded?

Hive Health was founded in 2021.

When was Hive Health's last funding round?

Hive Health's most recent funding round was for $125k (USD) in January 2021.

How much has Hive Health raised to-date?

As of Jan 1, 2021, Hive Health has raised a total of $125k (USD).

How many employees does Hive Health have?

Hive Health has 2 employees as of Apr 1, 2024.

Hive Health - Classification

Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • Asia
Revenue
  • Recurring
  • SaaS
Customer
  • Small Business
Main Product
  • Insurance
Tags
  • Healthtech